Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Gordon

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Surgery|January 1, 1991
A critical analysis of the largest reported mass fecal occult blood screening program in the United StatesJ B Morris, T A Stellato, B B Guy, et al.
World Journal of Surgery|October 1, 1985
Eight-year follow-up of adjuvant therapy for stage II breast cancerC A Hubay, N H Gordon, O H Pearson, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|February 24, 2001
Managed care for the Medicaid disabled: effect on utilization and costsR D Cebul, I Solti, N H Gordon, et al.
Journal of the National Cancer Institute|October 6, 1997
Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual diseaseL Cheng, N K Al-Kaisi, N H Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancersJ K Willson, J R Haaga, J E Trey, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 11, 1992
Primary tumor size. Relevance to breast cancer survivalJ P Crowe, N H Gordon, R R Shenk, et al.
Surgery|October 1, 1986
The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1991
Local-regional breast cancer recurrence following mastectomyJ P Crowe, N H Gordon, A R Antunez, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1994
Age does not predict breast cancer outcomeJ P Crowe, N H Gordon, R R Shenk, et al.
Gynecologic Oncology|August 6, 2000
A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinomaP G Rose, N H Gordon, N Fusco, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Surgery|January 1, 1991
A critical analysis of the largest reported mass fecal occult blood screening program in the United StatesJ B Morris, T A Stellato, B B Guy, et al.
World Journal of Surgery|October 1, 1985
Eight-year follow-up of adjuvant therapy for stage II breast cancerC A Hubay, N H Gordon, O H Pearson, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|February 24, 2001
Managed care for the Medicaid disabled: effect on utilization and costsR D Cebul, I Solti, N H Gordon, et al.
Journal of the National Cancer Institute|October 6, 1997
Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual diseaseL Cheng, N K Al-Kaisi, N H Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancersJ K Willson, J R Haaga, J E Trey, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 11, 1992
Primary tumor size. Relevance to breast cancer survivalJ P Crowe, N H Gordon, R R Shenk, et al.
Surgery|October 1, 1986
The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1991
Local-regional breast cancer recurrence following mastectomyJ P Crowe, N H Gordon, A R Antunez, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1994
Age does not predict breast cancer outcomeJ P Crowe, N H Gordon, R R Shenk, et al.
Gynecologic Oncology|August 6, 2000
A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinomaP G Rose, N H Gordon, N Fusco, et al.
Pageof 6